These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30839307)

  • 1. The selective TrkA agonist, gambogic amide, promotes osteoblastic differentiation and improves fracture healing in mice.
    Johnstone MR; Brady RD; Schuijers JA; Church JE; Orr D; Quinn JMW; McDonald SJ; Grills BL
    J Musculoskelet Neuronal Interact; 2019 Mar; 19(1):94-103. PubMed ID: 30839307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TrkB agonist, 7,8-dihydroxyflavone, impairs fracture healing in mice.
    Johnstone MR; Brady RD; Church JE; Orr D; McDonald SJ; Grills BL
    J Musculoskelet Neuronal Interact; 2021 Jun; 21(2):263-271. PubMed ID: 34059571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TrkA agonist gambogic amide augments skeletal adaptation to mechanical loading.
    Fioravanti G; Hua PQ; Tomlinson RE
    Bone; 2021 Jun; 147():115908. PubMed ID: 33713848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering circulating apolipoprotein E levels improves aged bone fracture healing.
    Huang R; Zong X; Nadesan P; Huebner JL; Kraus VB; White JP; White PJ; Baht GS
    JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31534056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin β4 administration enhances fracture healing in mice.
    Brady RD; Grills BL; Schuijers JA; Ward AR; Tonkin BA; Walsh NC; McDonald SJ
    J Orthop Res; 2014 Oct; 32(10):1277-82. PubMed ID: 25042765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice.
    Johnstone MR; Sun M; Taylor CJ; Brady RD; Grills BL; Church JE; Shultz SR; McDonald SJ
    Brain Inj; 2018; 32(2):257-268. PubMed ID: 29227174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
    Choudhary S; Halbout P; Alander C; Raisz L; Pilbeam C
    J Bone Miner Res; 2007 Jul; 22(7):1002-10. PubMed ID: 17371157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
    Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
    Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice.
    Bradaschia-Correa V; Josephson AM; Mehta D; Mizrahi M; Neibart SS; Liu C; Kennedy OD; Castillo AB; Egol KA; Leucht P
    J Bone Miner Res; 2017 Apr; 32(4):821-833. PubMed ID: 27869327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gambogic amide selectively upregulates TrkA expression and triggers its activation.
    Shen J; Yu Q
    Pharmacol Rep; 2015 Apr; 67(2):217-23. PubMed ID: 25712642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heated Tobacco Products Impair Cell Viability, Osteoblastic Differentiation, and Bone Fracture-Healing.
    Nishino K; Tamai K; Orita K; Hashimoto Y; Nakamura H
    J Bone Joint Surg Am; 2021 Nov; 103(21):2024-2031. PubMed ID: 34730563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice.
    Soung do Y; Gentile MA; Duong LT; Drissi H
    Bone; 2013 Jul; 55(1):248-55. PubMed ID: 23486186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
    Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
    Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair.
    Baht GS; Nadesan P; Silkstone D; Alman BA
    Bone; 2017 May; 98():31-36. PubMed ID: 28254468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo.
    Aghaloo TL; Amantea CM; Cowan CM; Richardson JA; Wu BM; Parhami F; Tetradis S
    J Orthop Res; 2007 Nov; 25(11):1488-97. PubMed ID: 17568450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
    Uchiyama S; Yamaguchi M
    J Cell Biochem; 2005 Aug; 95(6):1224-34. PubMed ID: 15962303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
    Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
    Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salidroside accelerates fracture healing through cell-autonomous and non-autonomous effects on osteoblasts.
    Guo XQ; Qi L; Yang J; Wang Y; Wang C; Li ZM; Li L; Qu Y; Wang D; Han ZM
    Cell Tissue Res; 2017 Feb; 367(2):197-211. PubMed ID: 27942852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
    Lee CH; Huang YL; Liao JF; Chiou WF
    Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.